Novel ionic liquids based on bis(trifluoromethylsulfonyl)imides of betaines, preparation and use for solubilization of metal oxides and hydroxides.

Koen Binnemans (Inventor), Christiane Anna Goerller-Walrand (Inventor), Peter Nockemann (Inventor), Ben. Thijs (Inventor)

Research output: Patent

Abstract

Purpose: To compare the prevalence of PFO in young and middle-aged patients with cryptogenic ischemic stroke (CS) and in normal population in northwestern China. Methods: Our case-control study included consecutive 318 young and middleaged patients with CS (36(plus or minus)8 years old, ranged from 18 to 50, 135 women) and 336 normal control subjects with matched age and sex (36(plus or minus)7 years old, ranged from 19 to 50, 139 women) for group comparisons. Stroke risk factors including hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease, atrial fibrillation, carotid atherosclerosis plagues and smoking, etc. were studied. Transesophageal echocardiography (TEE) tests were performed to detect the presence of PFO. The prevalence of PFO and difference of risk factor levels between the groups was compared. Then the odds ratios (OR) of a PFO was estimated in CS patients versus control subjects. Results: The prevalence of PFO was significant higher in patients with CS than in normal control subjects (145/318, 45.6% versus 46/336, 13.7%, P
Original languageEnglish
Patent numberWO2007147222A2
Publication statusPublished - 27 Dec 2007

Fingerprint

Hydroxides
Imides
Ionic Liquids
Betaine
Oxides
Metals
Stroke
Carotid Artery Diseases
Plague
Transesophageal Echocardiography
Hyperlipidemias
Atrial Fibrillation
Myocardial Ischemia
Case-Control Studies
China
Diabetes Mellitus
Smoking
Odds Ratio
Hypertension
Population

Keywords

  • ionic liq bistrifluoromethylsulfonylimide betaine

Cite this

Binnemans, K., Goerller-Walrand, C. A., Nockemann, P., & Thijs, B. (2007). Novel ionic liquids based on bis(trifluoromethylsulfonyl)imides of betaines, preparation and use for solubilization of metal oxides and hydroxides. (Patent No. WO2007147222A2). Katholieke Universiteit Leuven, Belg. .
Binnemans, Koen (Inventor) ; Goerller-Walrand, Christiane Anna (Inventor) ; Nockemann, Peter (Inventor) ; Thijs, Ben. (Inventor). / Novel ionic liquids based on bis(trifluoromethylsulfonyl)imides of betaines, preparation and use for solubilization of metal oxides and hydroxides. Katholieke Universiteit Leuven, Belg. . Patent No.: WO2007147222A2.
@misc{fdf0fd2f0abf43c0909ac7662288846c,
title = "Novel ionic liquids based on bis(trifluoromethylsulfonyl)imides of betaines, preparation and use for solubilization of metal oxides and hydroxides.",
abstract = "Purpose: To compare the prevalence of PFO in young and middle-aged patients with cryptogenic ischemic stroke (CS) and in normal population in northwestern China. Methods: Our case-control study included consecutive 318 young and middleaged patients with CS (36(plus or minus)8 years old, ranged from 18 to 50, 135 women) and 336 normal control subjects with matched age and sex (36(plus or minus)7 years old, ranged from 19 to 50, 139 women) for group comparisons. Stroke risk factors including hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease, atrial fibrillation, carotid atherosclerosis plagues and smoking, etc. were studied. Transesophageal echocardiography (TEE) tests were performed to detect the presence of PFO. The prevalence of PFO and difference of risk factor levels between the groups was compared. Then the odds ratios (OR) of a PFO was estimated in CS patients versus control subjects. Results: The prevalence of PFO was significant higher in patients with CS than in normal control subjects (145/318, 45.6{\%} versus 46/336, 13.7{\%}, P",
keywords = "ionic liq bistrifluoromethylsulfonylimide betaine",
author = "Koen Binnemans and Goerller-Walrand, {Christiane Anna} and Peter Nockemann and Ben. Thijs",
year = "2007",
month = "12",
day = "27",
language = "English",
publisher = "Katholieke Universiteit Leuven, Belg. .",
type = "Patent",
note = "WO2007147222A2",

}

Novel ionic liquids based on bis(trifluoromethylsulfonyl)imides of betaines, preparation and use for solubilization of metal oxides and hydroxides. / Binnemans, Koen (Inventor); Goerller-Walrand, Christiane Anna (Inventor); Nockemann, Peter (Inventor); Thijs, Ben. (Inventor).

Katholieke Universiteit Leuven, Belg. . Patent No.: WO2007147222A2.

Research output: Patent

TY - PAT

T1 - Novel ionic liquids based on bis(trifluoromethylsulfonyl)imides of betaines, preparation and use for solubilization of metal oxides and hydroxides.

AU - Binnemans, Koen

AU - Goerller-Walrand, Christiane Anna

AU - Nockemann, Peter

AU - Thijs, Ben.

PY - 2007/12/27

Y1 - 2007/12/27

N2 - Purpose: To compare the prevalence of PFO in young and middle-aged patients with cryptogenic ischemic stroke (CS) and in normal population in northwestern China. Methods: Our case-control study included consecutive 318 young and middleaged patients with CS (36(plus or minus)8 years old, ranged from 18 to 50, 135 women) and 336 normal control subjects with matched age and sex (36(plus or minus)7 years old, ranged from 19 to 50, 139 women) for group comparisons. Stroke risk factors including hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease, atrial fibrillation, carotid atherosclerosis plagues and smoking, etc. were studied. Transesophageal echocardiography (TEE) tests were performed to detect the presence of PFO. The prevalence of PFO and difference of risk factor levels between the groups was compared. Then the odds ratios (OR) of a PFO was estimated in CS patients versus control subjects. Results: The prevalence of PFO was significant higher in patients with CS than in normal control subjects (145/318, 45.6% versus 46/336, 13.7%, P

AB - Purpose: To compare the prevalence of PFO in young and middle-aged patients with cryptogenic ischemic stroke (CS) and in normal population in northwestern China. Methods: Our case-control study included consecutive 318 young and middleaged patients with CS (36(plus or minus)8 years old, ranged from 18 to 50, 135 women) and 336 normal control subjects with matched age and sex (36(plus or minus)7 years old, ranged from 19 to 50, 139 women) for group comparisons. Stroke risk factors including hypertension, diabetes mellitus, hyperlipidemia, ischemic heart disease, atrial fibrillation, carotid atherosclerosis plagues and smoking, etc. were studied. Transesophageal echocardiography (TEE) tests were performed to detect the presence of PFO. The prevalence of PFO and difference of risk factor levels between the groups was compared. Then the odds ratios (OR) of a PFO was estimated in CS patients versus control subjects. Results: The prevalence of PFO was significant higher in patients with CS than in normal control subjects (145/318, 45.6% versus 46/336, 13.7%, P

KW - ionic liq bistrifluoromethylsulfonylimide betaine

M3 - Patent

M1 - WO2007147222A2

PB - Katholieke Universiteit Leuven, Belg. .

ER -